Oohira A, Tamaki K, Ozeki K, Takamatsu K, Nogami H
Calcif Tissue Int. 1980;30(3):183-9. doi: 10.1007/BF02408626.
Proteoglycans were extracted with 4 M guanidine HCl solution containing protease inhibitors from various zones of human epiphyseal cartilages of the normally ossifying fibula and cartilaginous rudiment of the tibia of a 12-month-old boy with congenital absence of the tibia, when the knee disarticulation was performed. All the proteoglycan preparations from the epiphyseal cartilages were separated with a sucrose density gradient centrifugation into two components: a heavy, major component and a light one. The molecular size and the proportion of isomeric chondroitin sulfates of polysaccharides of the heavy component differed from those of the light one. The relative amounts of isomeric chondroitin sulfates in the polysacharide moieties of the components also varied among these zones. The glycosaminoglycan content in the rudimentary tibia was equal to that of the epiphyseal cartilage of the fibula. However, proteoglycan preparations showed neither the normal sedimentation profile with two peaks nor the zonal differences as to the proportion of isomeric chondroitin sulfates. These results suggest that the alterations in proteoglycan metabolism might be involved in the pathogenetic mechanisms producing the congenital limb defect.
在一名12个月大先天性胫骨缺如的男孩行膝关节离断术时,从正常骨化的腓骨的人骨骺软骨不同区域以及胫骨软骨原基中,用含有蛋白酶抑制剂的4M盐酸胍溶液提取蛋白聚糖。骨骺软骨的所有蛋白聚糖制剂通过蔗糖密度梯度离心分离为两个组分:一个重的主要组分和一个轻的组分。重组分多糖的分子大小和硫酸软骨素异构体的比例与轻组分不同。这些区域中各组分多糖部分中硫酸软骨素异构体的相对含量也有所不同。残端胫骨中的糖胺聚糖含量与腓骨骨骺软骨的相等。然而,蛋白聚糖制剂既没有显示出具有两个峰的正常沉降图谱,也没有显示出硫酸软骨素异构体比例的区域差异。这些结果表明,蛋白聚糖代谢的改变可能参与了导致先天性肢体缺陷的发病机制。